570 related articles for article (PubMed ID: 12948922)
1. Cutaneous and lingual papules as a sign of beta 2 microglobulin-derived amyloidosis in a long-term hemodialysis patient.
Uenotsuchi T; Imafuku S; Nagata M; Kiryu H; Morita K; Koga T; Furue M
Eur J Dermatol; 2003; 13(4):393-5. PubMed ID: 12948922
[TBL] [Abstract][Full Text] [Related]
2. Lichenoid skin lesions as a sign of beta 2-microglobulin-induced amyloidosis in a long-term haemodialysis patient.
Sato KC; Kumakiri M; Koizumi H; Ando M; Ohkawara A; Fujioka Y; Kon T
Br J Dermatol; 1993 Jun; 128(6):686-9. PubMed ID: 8338753
[TBL] [Abstract][Full Text] [Related]
3. New aspects in the pathogenesis of dialysis-related amyloidosis: pathophysiology of advanced glycation end products in renal failure.
Miyata T
Nihon Jinzo Gakkai Shi; 1996 May; 38(5):191-7. PubMed ID: 8699608
[TBL] [Abstract][Full Text] [Related]
4. beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis.
Miyata T; Oda O; Inagi R; Iida Y; Araki N; Yamada N; Horiuchi S; Taniguchi N; Maeda K; Kinoshita T
J Clin Invest; 1993 Sep; 92(3):1243-52. PubMed ID: 8376584
[TBL] [Abstract][Full Text] [Related]
5. Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1.
Miyata T; Inagi R; Iida Y; Sato M; Yamada N; Oda O; Maeda K; Seo H
J Clin Invest; 1994 Feb; 93(2):521-8. PubMed ID: 8113390
[TBL] [Abstract][Full Text] [Related]
6. Systemic distribution of beta 2-microglobulin-derived amyloidosis in patients who undergo long-term hemodialysis. Report of seven cases and review of the literature.
Gal R; Korzets A; Schwartz A; Rath-Wolfson L; Gafter U
Arch Pathol Lab Med; 1994 Jul; 118(7):718-21. PubMed ID: 8024407
[TBL] [Abstract][Full Text] [Related]
7. Ultrastructural localization of advanced glycation end products and beta2-microglobulin in dialysis amyloidosis.
Brancaccio D; Gallieni M; Niwa T; Braidotti P; Coggi G
J Nephrol; 2000; 13(2):129-36. PubMed ID: 10858976
[TBL] [Abstract][Full Text] [Related]
8. Beta 2-microglobulin modified with advanced glycation end products induces interleukin-6 from human macrophages: role in the pathogenesis of hemodialysis-associated amyloidosis.
Iida Y; Miyata T; Inagi R; Sugiyama S; Maeda K
Biochem Biophys Res Commun; 1994 Jun; 201(3):1235-41. PubMed ID: 8024566
[TBL] [Abstract][Full Text] [Related]
9. [Beta-2 microglobulin and amyloid osteoarthropathy in patients undergoing chronic hemodialysis].
Prinseau J; Baglin A; Benoit J; Leparc JM; Got C; Louis MF; Attar B; Fritel D
Ann Med Interne (Paris); 1989; 140(2):94-8. PubMed ID: 2662855
[TBL] [Abstract][Full Text] [Related]
10. [Mixed type amyloidomas, beta2 microglobulin and AL lambda, in a long term hemodialysis patient].
Menet E; Petit ML; Bridoux F; Touchard G; Duport G; Levillain P; Babin P
Nephrologie; 2001; 22(3):115-8. PubMed ID: 11436666
[TBL] [Abstract][Full Text] [Related]
11. Advanced glycation end product-modified beta2-microglobulin is a component of amyloid fibrils of primary localized cutaneous nodular amyloidosis.
Fujimoto N; Yajima M; Ohnishi Y; Tajima S; Ishibashi A; Hata Y; Enomoto U; Konohana I; Wachi H; Seyama Y
J Invest Dermatol; 2002 Mar; 118(3):479-84. PubMed ID: 11874487
[TBL] [Abstract][Full Text] [Related]
12. Morphological and immunohistochemical findings in dialysis-related amyloidosis. An analysis of 16 cases.
Solé M; Cardesa A; Palacín A; Muñoz-Gómez J; Campistol JM
Appl Pathol; 1989; 7(6):350-60. PubMed ID: 2701266
[TBL] [Abstract][Full Text] [Related]
13. Nodular macroglossia with combined light chain and beta-2 microglobulin deposition in a long-term dialysis patient.
Bandini S; Bergesio F; Conti P; Mancini G; Cerretini C; Cirami C; Rosati A; Caselli GM; Arbustini E; Merlini G; Ficarra G; Salvadori M
J Nephrol; 2001; 14(2):128-31. PubMed ID: 11411015
[TBL] [Abstract][Full Text] [Related]
14. Beta 2-microglobulin-related amyloidosis: where do we stand?
Gejyo F; Arakawa M
Nephrol Dial Transplant; 1995; 10(2):155-7. PubMed ID: 7753446
[No Abstract] [Full Text] [Related]
15. Beta 2-microglobulin amyloidosis: a sternoclavicular joint biopsy study in hemodialysis patients.
Zingraff J; Noël LH; Bardin T; Kuntz D; Dubost C; Drüeke T
Clin Nephrol; 1990 Feb; 33(2):94-7. PubMed ID: 2178825
[TBL] [Abstract][Full Text] [Related]
16. [A histological study on the synovial tissue of rat knee joints in the experimental beta 2-microglobulin derived amyloidosis].
Ueda T
Ryumachi; 1992 Aug; 32(4):308-17. PubMed ID: 1411793
[TBL] [Abstract][Full Text] [Related]
17. [Beta 2-microglobulin-induced amyloidosis. A new complication of long-term hemodialysis].
Ritz E; Bommer J; Zeier M
Dtsch Med Wochenschr; 1988 Feb; 113(5):190-6. PubMed ID: 3276494
[No Abstract] [Full Text] [Related]
18. Chronic intestinal pseudo-obstruction due to dialysis-related amyloid deposition in the propria muscularis in a hemodialysis patient.
Kanai H; Kashiwagi M; Hirakata H; Nagashima A; Tada S; Yao T; Nakamoto M; Nakamura S; Fujishima M
Clin Nephrol; 2000 May; 53(5):394-9. PubMed ID: 11305814
[TBL] [Abstract][Full Text] [Related]
19. Ureteral amyloid deposits of beta 2-microglobulin origin in both kidney recipients of 1 donor.
Buchholz NP; Moch H; Gasser TC; Linke RP; Thiel GT; Mihatsch MJ
J Urol; 1995 Feb; 153(2):399-401. PubMed ID: 7815597
[TBL] [Abstract][Full Text] [Related]
20. Bilateral beta 2-microglobulin amyloidomas of the buttocks in a long-term hemodialysis patient.
Tom Y; Htwe M; Chandra R; Smith-Behn DJ
Arch Pathol Lab Med; 1994 Jun; 118(6):651-3. PubMed ID: 8204014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
